(Q37209613)

19 August 2017

1 reference

title

Malignant mesothelioma: current status and perspective in Japan and the world (English)

1 reference

19 August 2017

1 reference

2

Fumihiro Tanaka

1 reference

19 August 2017

Seiki Hasegawa

1

1 reference

19 August 2017

publication date

8 July 2008

1 reference

General thoracic and cardiovascular surgery

19 August 2017

published in

1 reference

19 August 2017

volume

56

1 reference

19 August 2017

issue

7

1 reference

19 August 2017

page(s)

317-323

1 reference

https://scigraph.springernature.com/pub.10.1007/s11748-007-0243-2

19 August 2017

exact match

0 references

cites work

Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

CT in differential diagnosis of diffuse pleural disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Optimising survival in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Morphologic and functional imaging of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Imaging, staging and response evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

The role of PET in the surgical management of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Surgical treatment of malignant pleural mesothelioma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Extrapleural pneumonectomy is the preferred surgical management in the multimodality therapy of pleural mesothelioma: con argument

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Pleural mesothelioma: little evidence, still time to do trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Multidisciplinary treatment of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Multimodality approach in management of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Surgical approach to pleural diffuse mesothelioma in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Radical surgery for malignant pleural mesothelioma: results and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11748-007-0243-2

Mesothelioma--VATS biopsy and lung mobilization improves diagnosis and palliation

21 January 2018

1 reference

12 December 2020

Staging of malignant pleural mesothelioma: comparison of CT and MR imaging

1 reference

12 December 2020

The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma

1 reference

12 December 2020

Extended surgical staging for potentially resectable malignant pleural mesothelioma

1 reference

12 December 2020

A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma

1 reference

12 December 2020

The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma

1 reference

12 December 2020

Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma.

1 reference

12 December 2020

Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma

1 reference

12 December 2020

Laparoscopy: An important tool in the staging of malignant pleural mesothelioma

1 reference

12 December 2020

Importance of mediastinoscopy, bilateral thoracoscopy, and laparoscopy in correct staging of malignant mesothelioma before extrapleural pneumonectomy

1 reference

12 December 2020

Malignant mesothelioma

1 reference

12 December 2020

Staging in malignant mesothelioma

1 reference

12 December 2020

[Survey of surgical treatment of malignant pleural mesothelioma in Japan]

1 reference

12 December 2020

Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma

1 reference

12 December 2020

BTS statement on malignant mesothelioma in the UK, 2007.

1 reference

12 December 2020

Ten traps for the unwary in surgical series: A case study in mesothelioma reports

1 reference

12 December 2020

Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma

1 reference

12 December 2020

10.1007/S11748-007-0243-2

Identifiers

DOI

1 reference

19 August 2017

1 reference